Abiraterone Acetate Significantly Improves Overall Survival Of Patients With...
A study published today in The New England Journal of Medicine in patients with metastatic advanced prostate cancer following chemotherapy who were treated with abiraterone acetate plus...
View ArticleZYTIGA Phase 3 Study Results Re Metastatic Castration-Resistant Prostate Cancer
A study titled “Abiraterone and Increased Survival in Metastatic Prostate Cancer,” published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who...
View ArticleAflibercept Significantly Improves Survival In Previously Treated Metastatic...
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced data on Saturday 25 June showing that the investigational agent aflibercept, also known as VEGF Trap, significantly improved survival in...
View ArticleFDA Approves ERBITUX® (cetuximab) for First-Line Recurrent Locoregional or...
NEW YORK & INDIANAPOLIS–(BUSINESS WIRE)–(Eli Lilly and Company (NYSE: LLY) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved...
View ArticleVaccine for metastatic breast, ovarian cancer shows promise
“With this vaccine, we can clearly generate immune responses that lead to clinical responses in some patients,” said lead researcher James Gulley, M.D., Ph.D., director and deputy chief of the clinical...
View Article
